Last updated: August 18, 2026

Examiner: WRIGHT, ERIC BRANDON

Tech Center 1600 • Art Units: 1632 1638 1651

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

10.9%

§101 Eligibility

21.8%

§102 Novelty

25.5%

§103 Obviousness

30.9%

§112 Clarity

App #	Title	Status	Assignee
18707262	Methods of Targeting Mutant Cells	Non-Final OA	President and Fellows of Harvard College
18802201	NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3	Non-Final OA	Regeneron Pharmaceuticals, Inc.
18808470	METHOD FOR EVALUATING BIOLOGICAL ACTIVITY OF BIOMATERIALS	Non-Final OA	Axogen Corporation
18605786	GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF	Final Rejection	Indiana University Research and Technology Corporation

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.